AVIOR BIO
Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions. Using its disruptive drug delivery technology – Speedit™ Transmucosal Film Technology – we are positioned to develop products that bring unsurpassed value in efficacy and safety. Avior has an excellent management team, a strong advisory board, supportive partners, dedicated scientists, and knowledgeable clinicians that position us to be successful.
AVIOR BIO
Social Links:
Industry:
Biotechnology Neuroscience Pharmaceutical Product Design
Founded:
2017-01-01
Address:
Holly Springs, North Carolina, United States
Country:
United States
Website Url:
http://www.aviorbio.com
Total Employee:
11+
Status:
Active
Contact:
(919) 285- 3703
Email Addresses:
[email protected]
Total Funding:
731 K USD
Technology used in webpage:
U.S. Server Location
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Blackfynn
Blackfynn is a technology-driven, life-sciences company dedicated to transforming the way neurological diseases are diagnosed and treated.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Employees Featured
Investors List
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Debt Financing - Avior Bio
National Science Foundation
National Science Foundation investment in Grant - Avior Bio
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Debt Financing - Avior Bio
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Debt Financing - Avior Bio
Official Site Inspections
http://www.aviorbio.com
- Host name: 192.0.78.25
- IP address: 192.0.78.25
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
More informations about "Avior Bio"
Avior Bio – Offering Innovative Drug Delivery Technologies for …
Why Choose Avior Bio? Innovative Technology Speedit™ unlocks the potential of transmucosal films with its low-cost, high-bioavailability drug delivery platform, ensuring fast and effective …See details»
Avior Bio - Crunchbase Company Profile & Funding
Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions. Using its disruptive drug delivery …See details»
Avior Bio Inc. - LinkedIn
Avior Bio Inc. | 317 followers on LinkedIn. Innovative Drug Delivery | Improved Therapeutics | Avior is a clinical-stage pharmaceutical company located in Cary, North Carolina with Our primary ...See details»
Avior Bio 2025 Company Profile: Valuation, Funding
Deal Type Date Amount Raised to Date Post-Val Status Stage; 11. Debt - General: 02-Dec-2022: $200K: Completed: Clinical Trials - Phase 2: 10. …See details»
Avior Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Avior Bio, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 3 news, Technology Platform:Small molecule drug, Drug ...See details»
Case Study – Avior Bio
Tharimmune Secures Global Licensing for Avior’s AV104 Therapy Tharimmune Inc. Announces Licensing Agreement with Avior On November 6, Tharimmune Inc., based in Bridgewater, …See details»
Avior Bio - Overview, News & Similar companies | ZoomInfo.com
Sep 20, 2019 Popular Searches Avior Bio Inc Avior Inc Avior Avicenna Biosciences Inc Aviorbio SIC Code 28,283 NAICS Code 32,325 Show more. Avior Bio Org Chart. Niraj Vasisht. …See details»
Avior Inc. - VentureRadar
"Avior is a clinical stage, pharmaceutical company developing drugs for distressed neurological conditions. Using its disruptive drug delivery technology – Speedit™ Transmucosal Film …See details»
Avior Bio Inc. overview - services, products, equipment ... - Explorium
Aviorbio.com. 701 W Main St Suite 200 Durham, North Carolina 27701, US (919) 285-3703 [email protected] linkedin. Avior Bio Inc. Avior is a clinical-stage, biopharmaceutical company located …See details»
Avior Bio - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Avior Bio - Company Profile - Tracxn
Jan 9, 2025 Avior Bio - Developer of drugs to treat pruritus. Avior Bio has 5 competitors.See details»
Contact – Avior Bio
Get in Touch We’d love to hear from you! Whether you have questions about our innovative drug delivery technologies or are interested in partnering with us, feel free to reach out. …See details»
The latest R&D info about Avior Bio, Inc.: pipelines, patents, clinical ...
May 4, 2023 Find drug R&D information for Avior Bio, Inc.. including drug pipeline ... Avior Bio, Inc. has a total of 0 Literature ...See details»
Avior Bio, Inc. (Avior Bio, Inc.) - 药物管线_专利_临床试验_投融营 …
Www.aviorbio.com. 更新于：2025-01-23 ... "This license agreement allows the company to bring a clinical-stage asset into the organization as we shift into a business model focused on clinical …See details»
Holly Springs’ Avior Bio launches clinical trial of chronic itch ...
Jul 29, 2020 Holly Springs’ Avior Bio launches clinical trial of chronic itch therapy Date Published: July 29, 2020 HOLLY SPRINGS — Less than two years after launching, a small …See details»
Avior Inc. | North Carolina Biotech Center
Avior is a clinical-stage pharmaceutical company developing treatments for patients suffering from chronic liver disease (CLD) associated pruritus and pruritus in atopic dermatitis.See details»
Cary biotech startup lands licensing deal for potential chronic itchy ...
Nov 15, 2023 Avior Bio, a small Cary startup developing a treatment for pruritus, or chronic itchy skin, has secured an agreement to license its clinical-stage therapy to a New Jersey …See details»
Avior Bio’s Phase 1 Chronic Itch Therapy Trial Shows It's ‘safe and ...
Oct 27, 2020 A Holly Springs biotech startup is making early gains with its novel therapy for pruritus, or chronic itchy skin, often associated with liver disease. Avior Bio, a clinical-stage …See details»
Services – Avior Bio
Delivery Technologies Speedit™ Films (patent protected) unlock the technical potential of transmucosal films and offer a high-speed, low-cost, small-footprint drug delivery platform. Our …See details»
Establishing Canada’s first large-scale bioinnovation centre
2 days ago The Neptune BioInnovation Centre (NBC), a 51,000 sq ft facility on a 12.3 acre lot in Dartmouth, will offer leasable wet and dry lab space, warehouse and office spaces, and …See details»